Semaglutide/Tirzepatide Pen (60m)

$72.50

1 Unit
$72.5 per unit
$72.50
2 Units
$70.69 per unit (save 2% per unit)
$141.38
$145.00
3 Units
$68.88 per unit (save 5% per unit)
$206.64
$217.50
4 Units
$67.06 per unit (save 8% per unit)
$268.24
$290.00
5 Units
$65.25 per unit (save 10% per unit)
$326.25
$362.50
6 Units
$63.44 per unit (save 12% per unit)
$380.64
$435.00
7 Units
$61.63 per unit (save 15% per unit)
$431.41
$507.50
8 Units
$59.81 per unit (save 18% per unit)
$478.48
$580.00
9 Units
$58 per unit (save 20% per unit)
$522.00
$652.50
10 Units
$56.19 per unit (save 22% per unit)
$561.90
$725.00
Category:

Description

Tirzepatide and Semaglutide are peptide therapies that offer significant benefits for managing type 2 diabetes and obesity, with Tirzepatide demonstrating slightly superior efficacy in weight loss and glycemic control due to its dual action on GLP-1 and GIP receptors.
Both medications promote weight loss, improve blood sugar regulation, and reduce cardiovascular risk factors, though Tirzepatide’s dual-receptor mechanism provides enhanced metabolic benefits.

Weight Loss: Tirzepatide has shown greater effectiveness in clinical trials, with some participants achieving up to 20% body weight reduction, compared to Semaglutide’s average of around 15%.
Blood Sugar Control: Tirzepatide demonstrates superior HbA1c reduction compared to Semaglutide, particularly in patients with type 2 diabetes, due to its dual agonist activity.
Cardiovascular Benefits: Both drugs reduce cardiovascular risk factors such as high blood pressure, cholesterol levels, and insulin resistance; Tirzepatide may offer additional advantages due to its enhanced metabolic effects.
Appetite and Craving Suppression: Both medications reduce appetite and food intake by acting on brain regions that regulate hunger, but Tirzepatide’s dual action leads to stronger suppression of cravings.
Additional Benefits: Preliminary research suggests potential benefits in treating fatty liver disease and supporting bone health, with Tirzepatide showing protective renal effects such as reduced albuminuria.
Side Effects: Common side effects include nausea, vomiting, and diarrhea due to slowed gastric emptying; however, Tirzepatide may cause less nausea than Semaglutide due to the GIP component.

Related products